← Back to Search

Procedure

Nasogastric Tubes for Bronchiolitis

N/A
Recruiting
Led By David Spiro, MD, MPH
Research Sponsored by Arkansas Children's Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of bronchiolitis by the attending physician
Ages 0 months to 23 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 minutes
Awards & highlights

Study Summary

This trial aims to see if placing a tube in the nose can help reduce breathing difficulty in babies with bronchiolitis who need oxygen therapy.

Who is the study for?
This trial is for babies and toddlers up to 23 months old with bronchiolitis who are receiving oxygen through a high-flow nasal cannula. It's not suitable for those with tracheostomy, short gut syndrome, congenital heart disease, G-tube dependence, cranio-facial anomalies or bacterial pneumonia.Check my eligibility
What is being tested?
The study is testing if using nasogastric tubes to remove stomach contents can help ease breathing difficulties in young patients with bronchiolitis on high-flow oxygen therapy.See study design
What are the potential side effects?
Potential side effects of nasogastric tube placement may include discomfort in the nose or throat, gagging during the procedure, risk of tube misplacement into the lungs which could cause injury or infection.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My doctor diagnosed me with bronchiolitis.
Select...
I am under 2 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Respiratory status

Trial Design

1Treatment groups
Experimental Treatment
Group I: Nasogastric tube placementExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Arkansas Children's Hospital Research InstituteLead Sponsor
135 Previous Clinical Trials
5,029,305 Total Patients Enrolled
David Spiro, MD, MPHPrincipal InvestigatorAR Children's Hospital

Media Library

Nasogastric tube placement (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04480970 — N/A
Bronchiolitis Research Study Groups: Nasogastric tube placement
Bronchiolitis Clinical Trial 2023: Nasogastric tube placement Highlights & Side Effects. Trial Name: NCT04480970 — N/A
Nasogastric tube placement (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04480970 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age restriction for this clinical trial above or below 25 years?

"This medical trial requires that participants must be between 1 Day and 23 Months of age, as outlined in the eligibility specifications."

Answered by AI

Does this research currently have openings for participants?

"Affirmative. According to data on clinicaltrials.gov, this research project remains open for enrollment and is seeking 60 participants from 1 centre. The trial was first announced on August 3rd 2020 and the most recent update took place February 21st 2023."

Answered by AI

How many individuals are being accepted into the research endeavor?

"Affirmative. According to the information presented on clinicaltrials.gov, this study that was initially posted on August 3rd 2020 is still looking for participants. 60 individuals are sought after from a single medical centre."

Answered by AI

Is there an opportunity to participate in this research project?

"This research is targeting the recruitment of 60 infants between 24 hours old and 23 months with a confirmed diagnosis of bronchiolitis, who are currently receiving supplemental oxygen via high flow nasal cannula (4 liters or greater)."

Answered by AI
~13 spots leftby May 2025